Vimta Labs Earnings Call: Key Takeaways
Vimta Labs reported strong FY26 performance with Total Income reaching ₹4,163 Mn, up 19.5% YoY, and PAT at ₹775 Mn. Strategy focuses on expanding TIC services across Pharma, Food, and Electronics sectors.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
35 announcements
Vimta Labs reported strong FY26 performance with Total Income reaching ₹4,163 Mn, up 19.5% YoY, and PAT at ₹775 Mn. Strategy focuses on expanding TIC services across Pharma, Food, and Electronics sectors.
Vimta Labs Ltd reported revenue from operations of ₹109.2 Cr (+15.7% YoY) and net profit of ₹21.1 Cr (+15.3% YoY) for Q4 FY26.
Vimta Labs Limited reported its audited financial results for the year ended March 31, 2026, with total income reaching ₹416.28 Crore. The board recommended a dividend of ₹2 per share and approved incorporating a wholly owned subsidiary in the USA. Additionally, Dr. S. P. Vasireddi was reappointed as Executive Chairman for a five-year term.
Vimta Labs Ltd has scheduled a Board Meeting for May 6, 2026, to approve audited financial results for Q4 and FY 2025-26. The board will also consider recommending a dividend. The company's trading window is closed until 48 hours after the results announcement.
Vimta Labs Limited disclosed that it does not fall under the 'Large Corporate' category for FY 2026-27 per SEBI criteria. As of March 31, 2026, the company's outstanding borrowings stood at ₹3.33 Crore. The company maintains an 'A Stable' credit rating from CARE Ratings.